Ilaris 150 mg powder for solution for injection

Licence status
Authorised: 23/10/2009
Active substances
Canakinumab
Dosage Form
Powder for solution for injection
Licence number
EU/1/09/564/1-2
Licence holder
Novartis Europharm Limited

Product documents

Licence information

ATC code
L04AC Interleukin inhibitors, L04AC08 canakinumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
23/10/2009